What Are Autoimmune Diseases?

Autoimmune diseases, also called autoimmune disorders, are conditions in which the immune system loses its ability to distinguish the body's own tissue from foreign material and mounts a sustained attack against healthy cells. The healthy immune response depends on self-tolerance, a set of mechanisms that delete or suppress lymphocytes reactive to the body's own proteins. When tolerance fails, autoreactive T cells and antibodies known as autoantibodies drive chronic inflammation and progressive tissue damage. The National Institute of Allergy and Infectious Diseases counts more than 80 recognized autoimmune conditions, and a single patient may carry more than one at the same time.

The category spans rheumatology, endocrinology, neurology, gastroenterology, and dermatology, so it is defined by mechanism rather than by organ. Most autoimmune diseases are chronic, relapsing, and currently managed rather than cured, and most affect women disproportionately. Causation is understood as multifactorial: susceptibility genes, particularly in the human leukocyte antigen region, combine with environmental triggers such as infection, ultraviolet light, solvents, silica, or tobacco smoke, as summarized by the National Institute of Environmental Health Sciences.

Organ-Specific and Systemic Forms

Clinicians divide autoimmune conditions by how far the immune attack spreads. Organ-specific diseases target a single tissue: type 1 diabetes destroys the insulin-producing beta cells of the pancreas, Hashimoto thyroiditis and Graves disease target the thyroid, and multiple sclerosis attacks the myelin sheath of central nervous system axons. Systemic diseases affect many tissues at once. Systemic lupus erythematosus produces antinuclear antibodies that deposit as immune complexes in skin, joints, and kidneys, and rheumatoid arthritis inflames the synovial lining of joints throughout the body before eroding cartilage and bone. The National Institute of Arthritis and Musculoskeletal and Skin Diseases treats this distinction as the practical starting point for diagnosis, because the pattern of affected tissue narrows the differential quickly.

Diagnosis and Biomarkers

Diagnosis rests on clinical presentation combined with laboratory measurement of circulating autoantibodies and inflammatory markers. Indirect immunofluorescence on cultured cells remains the reference method for antinuclear antibody screening, while enzyme-linked immunosorbent assays and multiplex bead arrays quantify antibodies against specific antigens such as double-stranded DNA, cyclic citrullinated peptide, or thyroid peroxidase. Erythrocyte sedimentation rate and C-reactive protein track systemic inflammation but are not specific. Imaging contributes too: magnetic resonance imaging detects demyelinating lesions in multiple sclerosis, and musculoskeletal ultrasound identifies synovitis earlier than radiography. Biomedical engineering contributes microfluidic immunoassays, label-free biosensors, and continuous glucose monitors that make antibody panels and metabolic monitoring cheaper and faster, and machine learning applied to electronic health records is being tested as a way to shorten the diagnostic delay that many patients experience.

Immunomodulatory Treatment

Therapy aims to damp the autoimmune response while preserving enough immune function to control infection. Corticosteroids and conventional immunosuppressants such as methotrexate and azathioprine act broadly. Biologic agents act narrowly on defined targets: tumor necrosis factor inhibitors, interleukin-6 receptor blockers, and B cell depleting antibodies directed at CD20 each interrupt a specific step in the inflammatory cascade. Small-molecule Janus kinase inhibitors block cytokine signaling intracellularly. Where an organ has already failed, replacement therapy substitutes for the lost function, as with insulin pumps in type 1 diabetes and levothyroxine in hypothyroidism. Antigen-specific tolerance induction and engineered regulatory T cells are active research directions intended to restore selective tolerance rather than suppress immunity globally.

Applications

Research into autoimmune diseases connects to engineering practice in areas including:

• Point-of-care immunoassay and biosensor design for autoantibody detection
• Medical imaging analysis for lesion detection and disease staging
• Closed-loop drug delivery systems, including artificial pancreas controllers
• Wearable monitoring of inflammation, activity, and flare prediction
• Clinical decision support and predictive modeling from health records
• Bioprocess engineering for monoclonal antibody and cell therapy manufacture